Clinical study on holographic meridian scraping combined with traditional Chinese medicine nebulization for the treatment of dry eyes with lung yin deficiency

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2400083402

Enrollment

Unknown

Registered

2024-04-24

Start date

2024-05-01

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

dry eye

Interventions

Sodium Hyaluronate Eye Drops:During the study period, sodium hyaluronate eye drops were routinely used in both eyes, 4 times a day for 4 weeks as a course of treatment, and 1 course of treatment was t

Traditional Chinese medicine atomized eye smoke + sodium hyaluronate eye drops group:Traditional Chinese medicine atomized eye fumigation combined with sodium hyaluronate eye drops

Holographic meridian scraping + sodium hyaluronate eye drops group:Holographic meridian scraping combined with sodium hyaluronate eye drops

Holographic meridian scraping combined with traditional Chinese medicine atomization fumigation eye group:Holographic meridian scraping combined with traditional Chinese medicine atomizing smoked eyes

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: ? Meet the diagnostic criteria of traditional Chinese and Western medicine for dry eye; ? Age 18 to 75 years old; ? Clear consciousness and clear thinking, patients have good communication skills with others. ? The patient's informed consent.

Exclusion criteria

Exclusion criteria: ? Angular conjunctivitis, iritis, wheat granuloma and other ocular surface diseases; ? Suffering from a variety of diseases: bacterial, fungal, and viral infections, etc. ? Those with a history of mental illness who cannot communicate normally. ? Have skin diseases or systemic diseases around the eyes, such as systemic lupus erythematosus; ? Patients with hemorrhagic diseases, coagulation disorders and other contraindications to scraping; ? Have a history of eye-related surgery or eye trauma in the past 3 months; ? During pregnancy and lactation; ? Other major systemic diseases; ? Patients with poor adherence cannot actively cooperate with the completion of this observation treatment protocol on time. Those who meet any of the above requirements shall be excluded.

Design outcomes

Primary

Measure	Time frame
break-up time;	—

Secondary

Measure	Time frame
Eye Surface Disease Index Scale;TCM Syndrome Score Scale;Schirmer-I test;Fluorescent staining;	—

Countries

China

Contacts

Public ContactZhaohong Xieronggui

The First Affiliated Hospital of Hunan University of Traditional Chinese Medicine

742604945@qq.com+86 135 7485 9013

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026